BI Asset Management Fondsmaeglerselskab A S Boosts Stake in The Clorox Company (NYSE:CLX)

BI Asset Management Fondsmaeglerselskab A S increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 391.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 36,994 shares of the company's stock after buying an additional 29,460 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in Clorox were worth $6,008,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in Clorox in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC purchased a new stake in Clorox during the 4th quarter valued at $31,000. Asset Planning Inc purchased a new position in shares of Clorox in the 4th quarter worth $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in shares of Clorox in the fourth quarter worth $32,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Clorox stock traded up $0.71 during mid-day trading on Friday, hitting $138.28. The stock had a trading volume of 825,138 shares, compared to its average volume of 1,301,951. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm's 50 day moving average is $145.61 and its 200 day moving average is $155.68. The firm has a market capitalization of $17.03 billion, a P/E ratio of 37.78, a P/E/G ratio of 2.62 and a beta of 0.61. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the business earned $2.16 earnings per share. On average, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.53%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Barclays lowered their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. UBS Group cut their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Wells Fargo & Company decreased their price target on shares of Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 16th. Finally, Royal Bank of Canada reissued a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.